Beth A. Overmoyer MD, FACP

Dr. Overmoyer launched the Inflammatory Breast Cancer (IBC) Program at DF/BWCC in 2009, where she continues to serve as the principal investigator of many IBC research programs and clinical trials. She began her oncology career in 1989 at the University of Pennsylvania, where she trained in breast cancer and also participated in a major study in inflammatory breast cancer. She went on to develop the breast cancer program at the Cleveland Clinic and later developed two National Cancer Institute-sponsored studies on angiogenesis inhibitors and inflammatory breast cancer.